๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Abciximab useful in PTCA for patients with diabetes

Book ID
120874843
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
1998
Weight
178 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Feature topic: Clinical use of abciximab
Feature topic: Clinical use of abciximab: Coronary artery stenting for suboptimal PTCA results in acute myocardial infarction in patients treated with abciximab: Early and six-month outcome
โœ Murdock, David K. ;Logemann, Timothy ;Hoffmann, Mark T. ;Olson, Karen J. ;Engelm ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB ๐Ÿ‘ 2 views

Emergent percutaneous transluminal coronary angioplasty (PTCA) is an effective treatment for acute myocardial infarction. However, occasionally results of angioplasty are suboptimal due to coronary dissection or elastic recoil, leading to a high chance of recurrent ischemia. Coronary stents are occa

Diabetic patients treated with abciximab
Diabetic patients treated with abciximab and intracoronary stenting
โœ Brian L. Walton; Kim Mumm; Megumi Taniuchi; Howard I. Kurz; John M. Lasala ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 49 KB

## Abstract Diabetic patients are at greater risk for restenosis, recurrent ischemia, and complications following angioplasty than are their nondiabetic counterparts. This is a retrospective study identifying diabetic patients who were treated with abciximab and intracoronary stenting during the pe